Drugs Made In America Acquisition II Corp. (DMIIU) Operating Expenses (2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Operating Expenses of $235472.0 for Q4 2025, up 51.42% quarter-over-quarter from $155513.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Operating Expenses (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Operating Expenses for 1 consecutive years, with $235472.0 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 235,472.00 |
| Sep 30, 2025 | 155,513.00 |